1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
MDS - 794
Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
Poster Presenter
Authors
Part of Topic
Myelodysplastic Syndromes (MDS)
Sustained long-term control of terminal complement activity withravulizumab or danicopan add-on to ravulizumab in patients withparoxysmal nocturnal hemoglobinuria (PNH)